Serotonin release into plasma during common carotid artery thrombosis in rats

Stroke

Volumn 23, Issue 6, 1992, Pages 870-875

  Wester, Per ^a   Dietrich, W Dalton ^a   Prado, Ricardo ^a   Watson, Brant D ^a   Globus, Mordecai Y T ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Carotid arteries; Cerebral ischemia; Rats; Serotonin; Thrombosis; Transient

Indexed keywords

SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; CAROTID ARTERY THROMBOSIS; MALE; NONHUMAN; PHOTOSENSITIZATION; PRIORITY JOURNAL; RAT; SEROTONIN BLOOD LEVEL; SEROTONIN RELEASE; THROMBOCYTE AGGREGATION; THROMBUS;

ANIMAL; CAROTID ARTERIES; CAROTID ARTERY THROMBOSIS; MALE; MICROSCOPY, ELECTRON; MICROSCOPY, ELECTRON, SCANNING; OSMOLAR CONCENTRATION; RATS; RATS, INBRED STRAINS; SEROTONIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0026770673     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.23.6.870     Document Type: Article

References (45)

1. Krieger DT, Kolodny HD, Warner RRP: Serum serotonin in nervous system disease. Neurology 1964; 14:578-580
2. Welch KMA, Meyer JS, Teraura T, Hashi K, Shinmaru S: Isch-emic anoxia and cerebral serotonin levels. J Neurol Sci 1972; 16: 85-92
3. Wurtman RJ, Zervas NT: Monoamine neurotransmitters and the pathophysiology of stroke and central nervous system trauma. J Neurosurg 1974;40:34-36
4. Meyer JS, Welch KMA, Okamoto S, Shimazu K: Disordered neurotransmitter function: Demonstration by measurement of norepinephrine and 5-hydroxytryptamine in CSF of patients with recent cerebral infarction. Brain 1974;97:655-664
5. Mrsulja BB, Mrsulja BJ, Spatz M, Klatzo I: Brain serotonin after experimental vascular occlusion. Neurology 1976;26:785-787
6. Gaudet R, Welch KMA, Chabi E, Wang TP: Effect of transient ischemia on monoamine levels in the cerebral cortex of gerbils. J Neurochem 1978;30:751-757
7. Welch KMA, Meyer JS: Neurochemical alterations in cerebrospi-nal fluid in cerebral ischemia and stroke, in Wood JH (ed): Neurobiology of Cercbrospinal Fluid. New York, Plenum Publishing Corp, 1980, pp 325-336
8. Jellinger K and Riederer P: Zentrale Neurotransmitter bei zere-braler Ischámie und Hirninfarkt. Fortschr Neurol Psychiatr 1983; 54:91-123
9. Wester P, Puu G, Reiz S, Winblad B, Wester PO: Increased monoamine metabolite concentrations and cholinesterase activities in cerebrospinal fluid of patients with acute stroke. Acta Neurol Scand 1987a;76:473-479
10. Dietrich WD, Busto R, Ginsberg MD: Effect of the serotonin antagonist ketanserin on the hemodynamic and morphological consequences of thrombotic infarction. J Cereb Blood Flow Metab 1989a;9:812-820
11. Ferrarese C, Bassi S, Frattola L, Locatelli P, Piolti R, Trabucchi M: Different patterns of CSF neurotransmitter metabolism in patients with left or right hemispheric stroke. Ada Neurol Scand 1986;73: 581-585
12. Lamers KJB, Shoonderwaldt HC, Borkent MV, Theeuwes AGM, Doesburg WH, Wevers RA: The effects of acute cerebrovascular disease on serum and cerebrospinal fluid parameters. Clin Neurol Neurosurg 1987;89:23-29
13. Phebus LA, Clemens JA: Effects of transient, global, cerebral ischemia on striatal extracellular dopamine, serotonin and their metabolites. Life Sci 1989;44:1335-1342
14. Globus MY-T, Wester P, Busto R, Martinez E, Valdes I, Dietrich WD, Ginsberg MD: Ischemia-induced extracellular release of serotonin plays a role in CA1 neuronal cell death, (abstract) Ncurosci Abs 1991;17:1085
15. Reynolds JN, Baskys A, Carlen PL: The effects of serotonin on Af-methyl-D-aspartate and synapticalhJ evoked depolarizations in rat neocortical neurons. Brain Res 1988;456:286-292
16. Thompson JA, Wei EP, Kontos HA: Inhibition by ketanserin of serotonin-induced cerebral arteriolar constriction. Stroke 1984; 15: 1021-1024
17. Mayhan WG, Faraci FM, Heistad DD: Impairment of endotheli-um-dependent responses of cerebral arterioles in chronic hypertension. Am J Physiol 1987;253:1435 -1440
18. Garrison JC: Histamine, bradykinin, 5-hydroxytryptamine, and their antagonists, in Gilman AG, Rail TW, Nies AS, Tayler P (eds): Goodman and Gilman ‘s The Pharmacological Basis of Therapeutics. New York, Pergamon Press, 1990, pp 575-599
19. Crawford NV: Systemic venous platelet-bound and plasma free serotonin levels in non-carotid malignancy. Clin Chim Acta 1965; 12:274-281
20. Watson BD, Dietrich WD, Prado R, Ginsberg MD: Argon laser-induced arterial photothrombosis: Characterization and possible application to therapy of arteriove nous malformations. J Neurosurg 1987;66:748-754
21. Dietrich WD, Prado R, Watson BD: Photochemically stimulated blood-borne factors induce blood-brain barrier alterations in rats. Stroke 1988; 19:857-862
22. Futrell N, Watson BD, Dietrich WD, Prado R, Millikan C, Ginsberg MD: A new model of embolic stroke produced by photochemical injury to the carotid artery in the rat. Ann Neurol 1988;23:251-257
23. Dietrich WD, Prado R, Watson BD, Busto R, Ginsberg MD: Hemodynamic consequences of common carotid artery thrombosis and thrombogenically activated blood in rats. J Cereb Blood Flow Metab 1991;11:957-965
24. Luscher TF, Vanhoutte PM: The Endothelium: Modulator of Cardiovascular Function. Boca Raton, Fla, CRC Press, 1990
25. Wester P, Prado R, Watson BD, Globus M-YT, Leistra H, Dietrich WD: Measurement of serotonin in plasma by in vivo microdialysis during photochemically induced thrombosis: Methodological aspects, in Globus MY-T, Dietrich WD (eds): The Role of Neuro-transmitters in Brain Injury. Plenum Publishing Corp (in press)
26. Wester P, Gottfries J, Klintebäck F, Johansson K, Winblad B: Simultaneous liquid chromatographic determination of seventeen of the major monoamine neurotransmitters, precursors and metabolites: I. Optimization of the mobile phase using factorial designs and a computer program to predict chromatograms. J Chromatogr 1987b;415:261-274
27. Wester P, Gottfries J, Winblad B: Simultaneous liquid chromato-graphic determination of seventeen of the major monoamine neurotransmitters, precursors and metabolites: II. Assessment of human brain and cerebrospinal concentrations. J Chromatogr 1987c;415:275-288
28. Wilkinson L: systat: The System for Statistics. Evanston, Ill, SYSTAT, Inc, 1989
29. Ungerstedt U: Measurement of neurotransmitter release by intra-cranial dialysis, in Marsden CA (ed): Measurement of Neurotransmitter Release In Vivo, New York, John Wiley & Sons, Inc, 1984, pp 81-105
30. Benedict CR, Mathew B, Rex KA, Cartwright J, Sordahl LA: Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombus formation. Circ Res 1986;58:58-67
31. Watson BD, Dietrich WD, Prado R, Green BA: Photochemically induced vascular thrombosis (photothrombosis): Central nervous system consequences and clinical possibilities, in Gorio A, Perez-Polio JR, de Vellis J, Haber B (eds): Neural Development and Regeneration, NATO ASI Series, Vol H22, 1988, pp 507-524
32. Cohen RA, Zitnay K, Weisbrod R: Plate let-induced neurogenic coronary contractions due to accumulation of the false neurotrans-mitter, 5-hydroxytryptamine. J Clin Invest 1985;75:286-292
33. Cohen RA, Zitnay KM, Weisbrod RM: Accumulation of 5-hy-droxytryptamine leads to dysfunction of adrenergic nerves in canine coronary artery following intimal damage in vivo. Circ Res 1987;61:829-833
34. Ashton JH, Benedict CR, Fitzgerald C, Raheja S, Taylor A, Campbell WB, Buja LM, Willerson JT: Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. Circulation 1986;73:572-578
35. Thomas DP, Vane IR: 5-hydroxytryptamine in the circulation of the dog. Nature 1967;216:335-338
36. Westergaard E: Enhanced vesicular transport of exogenous perox-idase across cerebral vessels induced by serotonin. Acta Neuro-pathol 1975;32:27-42
37. Olsen S-P: A calcium-dependent reversible permeability increase in microvessels in frog brain, induced by serotonin. J Physiol 1985;361:103-113
38. Sharma HS, Olsson Y, Dey PK: Changes in blood-brain barrier and cerebral blood flow following elevation of circulating serotonin level in anesthetized rats. Brain Res 1990;517:215-223
39. Cremer JE, Seville MP: Regional brain blood flow, blood volume and hematocrit volume in adult rats. J Cereb Blood Flow Metab 1983;3:254-256
40. Solomon LS: Failure of buffered 5-hydroxytryptamine to increase brain capillary permeability to albumin in monkeys. J Neurosurg 1974;40:717-725
41. Saria A, Lundberg JM, Skofitsch G, Lembeck F: Vascular protein leakage in various tissues induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge. Naunyn Schmiedebergs Arch Pharmacol 1983;324:212-218
42. Harper AM, MacKenzie ET: Cerebral circulatory and metabolic effect of 5-hydroxytryptamine in anesthetized baboons. J Physiol 1977;271:721-733
43. Eidelman BH, Mendelow AD, McCalden TA, Bloom DS: Poten-tiation of the cerebrovascular response to intraarterial 5 -hydroxy-tryptamine. Am J Physiol 1978;234:H300-H304
44. Grome JJ, Harper AM: The effects of serotonin on local cerebral blood flow. J Cereb Blood Flow Metab 1983;3:71-77
45. Olesen J: Effect of serotonin on regional cerebral blood flow (rCBF) in man. Cephalalgia 1981;1:7-10